10.72

0.19% -0.02

After Hours: 10.72

Avita Medical Inc (RCEL)

Overview News Price History Option Chain Financials Why RCEL Down? Discussions Forecast Stock Split

Avita Medical Inc stock is traded at $10.72, with a volume of 85,235. It is down -0.19% in the last 24 hours and up +14.53% over the past month. Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Previous Close:

$10.74

Open:

$10.73

24h Volume:

85,235

Relative Volume:

0.59

Market Cap:

$276.66M

Revenue:

$50.14M

Net Income/Loss:

$-35.38M

P/E Ratio:

-8.7869

EPS:

-1.22

Net Cash Flow:

$-39.46M

1W Performance:

+1.52%

1M Performance:

+14.53%

6M Performance:

-33.13%

1Y Performance:

-26.63%

1-Day Range:

$10.58

$10.98

1-Week Range:

$10.24

$10.98

52-Week Range:

$7.51

$18.93

Avita Medical Inc Stock (RCEL) Company Profile

Name

Avita Medical Inc

Sector

Healthcare (1190)

Industry

Medical Devices (154)

Phone

661-568-1317

Address

28159 AVENUE STANFORD, VALENCIA, CA

Employee

207

Twitter

@AvitaMedical

Next Earnings Date

2024-08-08

Latest SEC Filings

RCEL's Discussions on Twitter

Avita Medical Inc Stock (RCEL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-27-23	Initiated	Cantor Fitzgerald	Overweight
Mar-02-21	Initiated	Piper Sandler	Overweight
Aug-27-20	Initiated	BofA Securities	Buy
Apr-21-20	Initiated	Oppenheimer	Outperform
Mar-03-20	Initiated	BTIG Research	Buy

Avita Medical Inc Stock (RCEL) Latest News

05:26 AM

AVITA Medical's SWOT analysis: regenerative medicine firm faces growth hurdles - Investing.com UK

05:26 AM

Sep 29, 2024

AVITA Medical (FRA:51KA) Revenue per Share : €1.96 (TTM As of Jun. 2024) - GuruFocus.com

Sep 29, 2024

AVITA Medical (FRA:51KA) Dividend Payout Ratio : 0.00 (As of Jun. 2024) - GuruFocus.com

Sep 29, 2024

AVITA Medical (FRA:51KA) Inventories, Raw Materials & Compo - GuruFocus.com

Sep 29, 2024

Sep 24, 2024

AVITA Medical, Inc. (NASDAQ:RCEL) Holdings Lowered by Bank of New York Mellon Corp - Defense World

Sep 24, 2024

Sep 20, 2024

AVITA Medical (FRA:51KA) Total Assets : €81.59 Mil (As of Jun. 2024) - GuruFocus.com

Sep 20, 2024

AVITA Medical (FRA:51KB) Free Cash Flow : €-53.82 Mil (TTM As of Jun. 2024) - GuruFocus.com

Sep 20, 2024

Sep 19, 2024

AVITA Medical (FRA:51KA) Momentum Rank : 4 (As of Sep. 29, 2024) - GuruFocus.com

Sep 19, 2024

Sep 13, 2024

AVITA Medical Inc (ASX:AVH) Q2 2024 Earnings Call Transcript Hig - GuruFocus.com

Sep 13, 2024

Top High Growth Tech Stocks To Watch In September 2024 - Simply Wall St

Sep 13, 2024

Sep 12, 2024

AVITA Medical to Present at 2024 Cantor Global Healthcare Conference - StockTitan

Sep 12, 2024

AVITA Medical to Present at 2024 Cantor Global Healthcare Conference - Morningstar

Sep 12, 2024

AVITA Medical (NASDAQ:RCEL) Stock Price Up 1.8% - MarketBeat

Sep 12, 2024

Sep 11, 2024